An experimental mRNA vaccine allowed people with high-risk melanoma to live longer, cancer-free, in a large, closely watched ...

In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.

Bianna speaks to Dr. Hussein Tawbi, oncologist and researcher at the University of Texas MD Anderson Cancer Center who leads the Phase 3 melanoma vaccine trial, and Dr. Ezekiel Emanuel, former Obama ...

For older adults, the flu vaccine could look a little different this year.

Combining a vaccine and immunotherapy approach could open new ways to treat cancer.

Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based vaccine—individually tailored to ...

Share on Pinterest Moderna’s new mRNA flu vaccine has been approved by the FDA for adults ages 50 years and older. FatCamera, E+/Getty Images The Food and Drug Administration (FDA) has approved ...

Moderna (MRNA) stock exploded 177% on melanoma vaccine trial success, marking the biggest S&P 500 gain in 20+ years. Analysts ...

The Food and Drug Administration has approved the first-ever mRNA flu vaccine, a shot that will use new technology to target evolving viruses and streamline vaccine production faster than traditional ...

The story has been refreshed with the latest market price action and a revised headline. Elon Musk said Wednesday that mRNA ...

A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful ...